Herbal Potential In Indonesia For Adjuvant Therapy To Corona Virus-19 Disease
European Journal of Molecular & Clinical Medicine,
2020, Volume 7, Issue 10, Pages 1696-1707
AbstractFrom December 2019 until December 11, 2020, SARS-Cov-2 has cause 1,576,516 deaths to start in Wuhan, China, to 220 countries worldwide. In most people who have good immunity, the disease’s symptoms disease is mild. However, in people with comorbidities and older people, it can develop into pneumonia, acute respiratory distress syndrome (ARDS), and many organ disorders. This review aims to reveal the herbal plants that potentials are dealing with and complementary therapy because no specific drug exists for the Covid -19. Based on kinds of literature showed that some herbs that have antiviral activity are the potential to be anti-SARS-Cov-2 diseases (Covid-19), especially curcumin that exists in 6,34% of traditional medicine formulas in Indonesia. Herbal products Stimuno® (Phyllantus niruri herb extract), New Divens®(Phyllantus niruri herb extract, Nigella sativa cement extract), Vipalbumin Plus® (Ophiocephalus striatus extract), and Lianhua Qingwen®(a combination of 13 herbs) that clinically proven to Helps improve the immune system. The National Agency of Drug and Food Control (NA-DFC) recently assisting 13 herbal drug research studies for covid-19 agents as an acceleration process to obtain distribution permits. This is way herbal medicine can be a complementary preventive and adjuvant therapy for COVID-19. However, this hypothesis requires experimental validation on the infection model of SARS-Cov-2 and COVID-19 patients. Many research further still need to find a specific cure for the disease by herbs, vaccines, or antivirals. Even though the number of Covid patients continues to increase in Indonesia and worldwide, but we always have any hope.
- Article View: 227
- PDF Download: 434